![Jim Broderick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Broderick
Founder at
Palleon Pharmaceuticals, Inc.
Profile
Dr. James W.
Broderick, MD, is a Chief Executive Officer & Director at Palleon Pharmaceuticals, Inc. He is on the Board of Directors at Palleon Pharmaceuticals, Inc. Dr. Broderick was previously employed as a Partner by LSV Capital Management LLC, a Chairman by RA Pharmaceuticals, Inc., a Co-Founder by SetPoint Medical Corp., a Chairman by Promedior, Inc., an Independent Director by OncoMed Pharmaceuticals, Inc., a Partner by Morgenthaler Management Corp., and a Principal by Mercer Management Consulting, Inc. He also served on the board at CardioPolymers, Inc., NexTag, Inc., Spine Wave, Inc. and Trellis Bioscience, Inc. He received his undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from the University of Massachusetts.
Jim Broderick active positions
| Companies | Position | Start |
|---|---|---|
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Founder | 2014-12-31 |
Former positions of Jim Broderick
| Companies | Position | End |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Director/Board Member | 2013-12-31 |
Trellis Bioscience, Inc.
 Trellis Bioscience, Inc. BiotechnologyHealth Technology Develops treatments for infectious diseases, cancer and oncology indications | Corporate Officer/Principal | - |
NexTag, Inc.
 NexTag, Inc. Information Technology ServicesTechnology Services Develops online monetization and traffic acquisition technologies | Corporate Officer/Principal | - |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Private Equity Investor | - |
SetPoint Medical Corp.
 SetPoint Medical Corp. Medical SpecialtiesHealth Technology Develops bio-electronic medicine therapy devices to treat chronic autoimmune conditions | Founder | - |
Training of Jim Broderick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Develops treatments for infectious diseases, cancer and oncology indications | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
SetPoint Medical Corp.
SetPoint Medical Corp. Medical SpecialtiesHealth Technology Develops bio-electronic medicine therapy devices to treat chronic autoimmune conditions | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Spine Wave, Inc.
 Spine Wave, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of spinal disorders | Health Technology |
Mercer Management Consulting, Inc.
 Mercer Management Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NexTag, Inc.
NexTag, Inc. Information Technology ServicesTechnology Services Develops online monetization and traffic acquisition technologies | Technology Services |
Promedior, Inc.
 Promedior, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics to treat fibrotic diseases | Health Technology |
Morgenthaler Management Corp.
 Morgenthaler Management Corp. Investment ManagersFinance Morgenthaler invests in companies located in the United State with an EBITDA of USD 8 - 40 million. The firm focuses on companies operating in the fields of information technology and life sciences sectors. It provides financing for early and later stage capital requirements. | Finance |
CardioPolymers, Inc.
 CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology Provides novel biocompatible polymer implant therapies to treat cronic heart failures | Health Technology |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Jim Broderick
